FHND9041 Versus Afatinib for Non-small Cell Lung Cancer
Clinical trial NCT06759857 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06759857
- Sponsor
- Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-01
- Primary completion
- 2025-03-04
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.